Improved detection of Babesia bigemina from various geographical areas in Africa using quantitative PCR and reverse line blot hybridisation

2020 ◽  
Vol 11 (4) ◽  
pp. 101415
Author(s):  
Hein Stoltsz ◽  
Charles Byaruhanga ◽  
Milana Troskie ◽  
Marcus Makgabo ◽  
Marinda C. Oosthuizen ◽  
...  
Mycoses ◽  
2011 ◽  
Vol 54 ◽  
pp. 5-11 ◽  
Author(s):  
Q. Lu ◽  
A. H. G. Gerrits van den Ende ◽  
G. S. de Hoog ◽  
R. Li ◽  
I. Accoceberry ◽  
...  

Pathology ◽  
2011 ◽  
Vol 43 (5) ◽  
pp. 488-494 ◽  
Author(s):  
Yongyan Cao ◽  
Fanrong Kong ◽  
Fei Zhou ◽  
Meng Xiao ◽  
Qinning Wang ◽  
...  

Pathogens ◽  
2021 ◽  
Vol 10 (11) ◽  
pp. 1431
Author(s):  
Karla Georges ◽  
Chuckwudozi Ezeokoli ◽  
Godwin Isitor ◽  
Alex Mutani ◽  
Olivier Sparagano ◽  
...  

This study compared two methods to detect cases of canine ehrlichiosis in a field setting. One method was a polymerase chain reaction for the 16S rRNA gene followed by reverse line blot hybridisation with genera and species-specific probes for Anaplasma/Ehrlichia. The second method was an autologous cell culture of peripheral leucocytes isolated from heparinised blood and maintained in a homologous canine serum in Dulbecco’s Modified Eagle medium without antibiotics. The cultures were examined under light microscopy for inclusion bodies after 48 h. Leucocytes were successfully propagated for 20 of the 34 samples submitted for autologous cell culture. Inclusion bodies were observed after cell culture in leucocytes of eight dogs. Two dogs were positive to the Anaplasma/Ehrlichia genera probe and six dogs were positive to the E. canis probe after reverse line blot hybridisation. There was acceptable agreement between reverse line blot hybridisation and cell culture results. Both reverse line blot hybridisation and autologous cell cultures can be used to detect E. canis in subclinical and clinical cases of disease. A definitive diagnosis of E. canis is best achieved by a combination of clinical signs, positive autologous cell culture, and reverse line blot hybridisation results.


2001 ◽  
Vol 49 (2) ◽  
pp. 191-195
Author(s):  
S. H. Basagoudanavar ◽  
J. R. Rao ◽  
Swati Omanwar ◽  
A. K. Tiwari ◽  
R. K. Singh ◽  
...  

A highly reproducible, dominant, monomorphic fragment of 473 base pair (bp) amplified from the genome of Trypanosoma evansi by arbitrary primer — polymerase chain reaction (AP-PCR) was labelled with digoxigenin and investigated for its potential as DNA probe. Dot-blot hybridisation of total genomic DNA with the probe proved useful in detecting bubaline, cameline and equine strains of T. evansi down to 10 pg of parasite template DNA. No cross-hybridisation was seen with Babesia bigemina, Theileria annulata and the bubaline host DNA. This probe may facilitate laboratory identification of T. evansi in developing countries, without the inherent risk associated with radioisotopes.


2009 ◽  
Vol 160 (1-2) ◽  
pp. 171-174 ◽  
Author(s):  
Dana Čerňanská ◽  
Barbara Paoletti ◽  
Ivica Kráľová-Hromadová ◽  
Raffaella Iorio ◽  
Patrícia Čudeková ◽  
...  

2001 ◽  
Vol 99 (4) ◽  
pp. 273-286 ◽  
Author(s):  
K Georges ◽  
G.R Loria ◽  
S Riili ◽  
A Greco ◽  
S Caracappa ◽  
...  

2010 ◽  
Vol 01 (03) ◽  
pp. 144-144
Author(s):  
Alexander Kretzschmar

Der Vorteil einer Konsolidierungstherapie mit 90Yttrium-Ibritumomab-Tiuxetan (Zevalin®) beim follikulären Lymphom (FL) wurde in der FIT-Studie anhand der Verbesserung des progressionsfreien Überlebens belegt. Eine quantitative PCR-Analyse (qPCR) der Studie zeigt nun einen weiteren Vorteil der Konsolidierung mit 90Yttrium- Ibritumomab-Tiuxetan: Der Antikörper führt bei 90% der initial bcl-2- positiven Patienten zur bcl-2- Negativität und parallel zu einer Verlängerung des progressionsfreien Überlebens auf über 40 Monate.


Sign in / Sign up

Export Citation Format

Share Document